A schematic diagram illustrating the diverse pain modalities and their associated mechanisms is presented in Fig
Wegovy has been FDA-approved since June 2021 for chronic weight management in adults with a BMI of 30 or above, or 27 and above with a weight-related comorbidity
Non-GLP-1 alternatives If GLP-1 medications are too expensive, there are more affordable alternatives that can still help you lose weight and maintain the weight loss
Another key benefit is deeper, more restorative sleep, which directly impacts recovery, energy levels, and overall performance
I know exactly what youre thinking
Tabe Y, Contractor R, Radke S, Andreeff M , Konopleva M